share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Kelly Jason R

Ginkgo Bioworks | 4：持股變動聲明-高管 Kelly Jason R

SEC announcement ·  01/05 00:00
Moomoo AI 已提取核心訊息
Jason R. Kelly, associated with Ginkgo Bioworks Holdings, Inc. [DNA], completed the sale of 200,000 shares of Class A Common Stock over two transactions on January 3 and 4, 2024. The shares were sold at prices ranging from $1.544 to $1.555 per share, resulting in a total market value of $309,900. Following these transactions, Kelly's direct holdings in the company amount to 3,894,680 shares. The sales were executed in the open market.
Jason R. Kelly, associated with Ginkgo Bioworks Holdings, Inc. [DNA], completed the sale of 200,000 shares of Class A Common Stock over two transactions on January 3 and 4, 2024. The shares were sold at prices ranging from $1.544 to $1.555 per share, resulting in a total market value of $309,900. Following these transactions, Kelly's direct holdings in the company amount to 3,894,680 shares. The sales were executed in the open market.
與 Ginkgo Bioworks Holdings, Inc. [DNA] 相關的傑森·凱利於2024年1月3日和4日通過兩筆交易完成了20萬股A類普通股的出售。這些股票的出售價格從每股1.544美元到1.555美元不等，總市值爲309,900美元。這些交易之後，凱利在該公司的直接持股量爲3,894,680股。銷售是在公開市場上執行的。
與 Ginkgo Bioworks Holdings, Inc. [DNA] 相關的傑森·凱利於2024年1月3日和4日通過兩筆交易完成了20萬股A類普通股的出售。這些股票的出售價格從每股1.544美元到1.555美元不等，總市值爲309,900美元。這些交易之後，凱利在該公司的直接持股量爲3,894,680股。銷售是在公開市場上執行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息